Evolution of cutaneous lymphoid hyperplasia to cutaneous T-cell lymphoma

COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).

Leukemia·2010

Mantle cell lymphoma in the orbital and adnexal region.

The British journal of ophthalmology·2009

Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.

Leukemia·2008

Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma.

Histopathology·2008

Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders.

The British journal of dermatology·2008

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.

Leukemia·2007

Extramammary Paget Disease: A Review.

Clinical and experimental dermatology·2026

Effectiveness, safety and tolerability of Ozenoxacin 2% lotion vs Clindamycin 1% lotion in mild to moderate truncal acne: An open label randomized controlled clinical trial.

Clinical and experimental dermatology·2026

Body composition of hidradenitis suppurativa compared to psoriasis and healthy controls.

Clinical and experimental dermatology·2026

Old molecule, new scrutiny: Benzoyl peroxide in dermatology.

Clinical and experimental dermatology·2026

A review of the use of cutaneous cryotherapy in dermatology.

Clinical and experimental dermatology·2026

HPV Vaccination as Treatment for Cutaneous Diseases: Beyond Prevention.

Clinical and experimental dermatology·2026

Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

Cureus·2026

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

ACS central science·2026

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Frontiers in immunology·2026

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

Frontiers in oncology·2026

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

BMC medicine·2026

Related Experiment Videos

Evolution of cutaneous lymphoid hyperplasia to cutaneous T-cell lymphoma

Related Concept Videos

COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).

Mantle cell lymphoma in the orbital and adnexal region.

Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.

Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma.

Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders.

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia.

Extramammary Paget Disease: A Review.

Effectiveness, safety and tolerability of Ozenoxacin 2% lotion vs Clindamycin 1% lotion in mild to moderate truncal acne: An open label randomized controlled clinical trial.

Body composition of hidradenitis suppurativa compared to psoriasis and healthy controls.

Old molecule, new scrutiny: Benzoyl peroxide in dermatology.

A review of the use of cutaneous cryotherapy in dermatology.

HPV Vaccination as Treatment for Cutaneous Diseases: Beyond Prevention.

Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

Related Experiment Videos

Evolution of cutaneous lymphoid hyperplasia to cutaneous T-cell lymphoma

Related Concept Videos

Related Articles